Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract, with KIT mutations driving approximately 75% to 80% of cases.

RGCB scientists discover how malaria parasites exploit young blood cells to resist artemisinin, challenging traditional views on drug resistance.